Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey

Orphanet Journal of Rare Diseases
Linda Rossi-SemeranoMAIL1 (Maladies Auto-inflammatoires et Anti-IL-1) study Group on behalf of CRI (Club Rhumatisme et Inflammation)

Abstract

Despite their limited licensed indications, anti-interleukin-1 (anti-IL-1) agents are often used in clinical practice for an increasing number of auto-inflammatory diseases. We conducted a national cross-sectional observational study from January 2011 to January 2013 to record the off-label use of such agents in France. We aimed to estimate the off-label use of anti-IL-1 treatments in France, assess their efficacy in rare diseases, and increase the reporting of their possible side effects. Physicians answered a questionnaire that covered patient and disease data, anti-IL-1 agent use, efficacy and adverse events. The study involved adult or paediatric patient who had received an anti-IL-1 agent after January 2005 in France. In total, 189 patients from 38 centres were included. The main diseases were adult-onset Still's disease (AOSD) (35), gout (28), systemic juvenile idiopathic arthritis (27), cryopyrin-associated periodic syndrome (CAPS) (21), familial Mediterranean fever (14) and mevalonate kinase deficiency (12). The main off-label used agent was anakinra, used at least once for 185 patients, with canakinumab used for 25. Anakinra was effective in most patients (90%), with higher complete clinical response rates for Schnitzl...Continue Reading

References

Jun 20, 2003·The New England Journal of Medicine·Philip N HawkinsMichael F McDermott
Aug 13, 2005·Annals of the Rheumatic Diseases·H D de KoningJ W M van der Meer
Jan 7, 2006·Annals of the Rheumatic Diseases·R M FleischmannB Appleton
Jan 13, 2006·Nature·Fabio MartinonJürg Tschopp
Aug 11, 2006·The New England Journal of Medicine·Raphaela Goldbach-ManskyDaniel L Kastner
Jun 6, 2009·The New England Journal of Medicine·Helen J LachmannUNKNOWN Canakinumab in CAPS Study Group
Oct 13, 2010·Scandinavian Journal of Rheumatology·J T GranP Aukrust
Oct 23, 2010·Arthritis and Rheumatism·Helen J LachmannPhilip N Hawkins
Dec 17, 2010·The Journal of Rheumatology·Seza OzenMeral Calguneri
Feb 1, 2011·Seminars in Arthritis and Rheumatism·Ulrich MeinzerIsabelle Koné-Paut
Mar 2, 2011·Arthritis and Rheumatism·Jasmin B Kuemmerle-DeschnerSusanne M Benseler
Jun 21, 2011·Arthritis Research & Therapy·Katerina LaskariHaralampos M Moutsopoulos
Jun 29, 2012·Rheumatology·Caroline GaleottiIsabelle Koné-Paut
Jul 4, 2012·Annals of the Rheumatic Diseases·Nienke Ter HaarUNKNOWN Paediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever/Eurotraps Projects
Dec 12, 2012·Arthritis Care & Research·Cecilia GiampietroUNKNOWN CRI (Club Rhumatismes et Inflammation)
Dec 21, 2012·The New England Journal of Medicine·Nicolino RupertoUNKNOWN PRCSG
May 8, 2013·Arthritis Care & Research·Pradipta GhoshGregory C Gardner
Oct 18, 2013·Orphanet Journal of Rare Diseases·Isabelle TouitouUNKNOWN CeRéMAI, French reference center for autoinflammatory diseases
Jan 17, 2014·Arthritis Research & Therapy·Sébastien OttavianiPhilippe Dieudé
Apr 18, 2014·Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti·P SzturzJ Mayer

❮ Previous
Next ❯

Citations

Aug 28, 2015·Expert Review of Clinical Immunology·Isabelle Koné-Paut, Caroline Galeotti
Mar 5, 2016·Cardiology Research and Practice·Shankar BaskarAndrew Zeft
Sep 20, 2015·Current Rheumatology Reports·Gerd Horneff
Sep 8, 2016·Expert Opinion on Biological Therapy·Ruby Haviv, Philip J Hashkes
Oct 6, 2016·Revista clínica española·A González GarcíaN Ortego Centeno
Apr 30, 2017·Expert Review of Clinical Immunology·F La TorreR Cimaz
May 26, 2017·Expert Review of Clinical Immunology·Dae Hyun Yoo
Oct 17, 2018·Expert Review of Clinical Immunology·Santos CastañedaMiguel A González-Gay
Jan 4, 2017·The Journal of Rheumatology·Katerina LaskariPetros P Sfikakis
Jan 18, 2019·Expert Review of Clinical Immunology·Judith Sánchez-ManubensJordi Anton
Aug 6, 2019·Expert Opinion on Biological Therapy·Dae Hyun Yoo
Sep 6, 2017·Expert Review of Clinical Immunology·Piero RuscittiRoberto Giacomelli
Nov 27, 2019·Rheumatology·Sebastiaan J VastertFabrizio de Benedetti
May 31, 2019·Clinical Reviews in Allergy & Immunology·Sheng LiJianjun Qiao
Apr 13, 2017·Frontiers in Pharmacology·Perrine Dusser, Isabelle Koné-Paut
Jul 22, 2018·Nature Reviews. Drug Discovery·Matthew S J ManganEicke Latz
Sep 19, 2018·Case Reports in Pediatrics·Nadia K RafiqPaul A Brogan
Apr 25, 2019·EMBO Molecular Medicine·Sofie VoetGeert van Loo
Dec 17, 2019·Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders·Ena SharmaRobert Terkeltaub
Apr 1, 2017·Expert Review of Clinical Immunology·Huri Ozdogan, Serdal Ugurlu
Jul 30, 2017·Zeitschrift für Rheumatologie·C M HedrichM Aringer
Feb 14, 2019·Arthritis Research & Therapy·François VercruysseMarie-Elise Truchetet
Apr 20, 2019·International Journal of Molecular Sciences·Alessandra BettiolFlorenzo Iannone
Apr 26, 2019·European Heart Journal. Case Reports·Anchalia ChandrakumaranAntonio Abbate
Sep 14, 2019·Nature Reviews. Rheumatology·Charles Anthony Dinarello
Oct 10, 2018·Frontiers in Pharmacology·Paola GalozziPaolo Sfriso
Jan 21, 2020·Expert Review of Clinical Immunology·Paolo SfrisoPaola Galozzi
Jul 17, 2020·Frontiers in Immunology·Véronique HentgenSophie Georgin-Lavialle
Apr 30, 2017·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C M HedrichM Aringer
May 18, 2018·Clinical Rheumatology·Jurgen SotaUNKNOWN “Working Group” of Systemic Autoinflammatory Diseases of SIR (Italian Society of Rheumatology)
Aug 9, 2020·Paediatrics & Child Health·Paul Tsoukas, Ronald M Laxer
Oct 21, 2020·Expert Opinion on Drug Safety·Giulio CavalliLorenzo Dagna
Dec 10, 2020·Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia·Laurence Gusdorf, Dan Lipsker
Jul 4, 2020·Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia·Isabelle Koné-Paut, Perrine Dusser

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here